• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CARDIOPULMONARY GMBH HLS SET ADVANCED 7.0; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CARDIOPULMONARY GMBH HLS SET ADVANCED 7.0; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number BE-HLS 7050#HLS SET ADVANCED 7.0
Device Problems Improper Flow or Infusion (2954); Pressure Problem (3012)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/29/2020
Event Type  malfunction  
Event Description
Device concerned: cec circuit for cardiohelp ref bf hls 7050 / lot 70138124 and cardiohelp console (serial number (b)(4)).Date of incident: (b)(6) 2020.Problem observed: a few hours after setting up ecmo, there was initially an increase in delta p on the cardiohelp display, which put the console in alarm.No repercussion on the patient, the 2 cannulas are of different color, there is not a suspicion of a clot on the membrane (patient with acute hepatocellular insufficiency with factor v at 8%), the blood gases on the patient and the 'ecmo are correct.The ecmo anticoagulation is okay.After one hour, persistence of the increase in delta p which increases to 343 mm hg.Test of vascular filling and reduction of doses of norepinephrine: no effect.This causes a drop in flow on the console and results in hypoperfusion of the patient ( pa, sa o2), and a degradation of the patient's vital functions.Action taken: change of the ecmo console + oxygenator + cec circuit.No more problems noted, improved patient condition." complaint id: (b)(4).
 
Manufacturer Narrative
The product was investigated in the laboratory of maquet cardiopulmonary with the following results: during visual inspection of the product it was determined that the blood outlet side of the oxygenator was clotted.Thus the product has to be cleaned several times with sodium hypochlorite.Additionally a tightness test was performed, no leakages were detected.Afterwards the hls module was connected to the cardiohelp device.All pressure sensors of the hls module were shown up at the cardiohelp's monitor.Furthermore the hls module was tested for the delta p measurement.The pressure parameters were calibrated and the delta p was set to 100mmhg.After 30 minutes no change of the value was observed, after 1 one the value was still constant.No inoperability of the pressure measurement sensors of the hls module was detected.Based on the results of the laboratory investigation no root cause could be determined.As a completely clotted blood outlet side was detected during visual inspection of the product the most probable cause of the reported event could be clotting leading to a blockage of the oxygenator and the rising delta pressure.Due to the impaired blood flow the oxygenation performance of the oxygenator was decreased.According to the ifu hls set advanced 5.0 / 7.0 1.5 / g-270 / 02 following causes could led to coagulation: no anticoagulation or insufficient anticoagulation causes occlusion of the extracorporeal circulation and the patient circuit.This can lead to inadequate patient support, hemolysis or thrombus formation in the patient.Weigh the benefits of extracorporeal circulation against the risk of systemic anticoagulation.Use anticoagulants; e.G.Heparin or argatroban.Check the effect of anticoagulants at regular intervals by measuring the act (activated clotting time).Ensure that the act value does not fall below the value which is appropriate for the application.Check the coagulation status of the patient's blood regularly.The protocol for coagulation management is the responsibility of the user in charge.A device history record review was performed.There were no references found, which are indicating a nonconformance of the product in question.Thus the reported failure could be confirmed but was not be attributed to a device related malfunction.The occurrence rate was calculated for the reported issue and it was determined that this is not a systemic issue.Therefore, no remedial action is required the occurrence rate related to the reported issue is currently being monitored as part of maquet cardiopulmonary¿s trending program and additional investigations or corrections will be implemented in case of adverse trending.
 
Event Description
Complaint id:(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HLS SET ADVANCED 7.0
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
MAQUET CARDIOPULMONARY GMBH
neue rottenburger strasse 37
hechingen
MDR Report Key10377954
MDR Text Key202005888
Report Number8010762-2020-00247
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
PMA/PMN Number
K112360
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign,health profe
Type of Report Initial,Followup
Report Date 10/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberBE-HLS 7050#HLS SET ADVANCED 7.0
Device Catalogue Number701047753
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/13/2020
Initial Date Manufacturer Received 08/03/2020
Initial Date FDA Received08/07/2020
Supplement Dates Manufacturer Received10/06/2020
Supplement Dates FDA Received10/08/2020
Is This a Reprocessed and Reused Single-Use Device? Yes
Patient Sequence Number1
-
-